Eugene, OR, United States of America

Gregory Martin Harrowe

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Xoma Technology Ltd.. Active years: 2015-2021.

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Gregory Martin Harrowe

Introduction:

Gregory Martin Harrowe, a talented inventor hailing from Eugene, Oregon, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Gregory Martin Harrowe's latest patents include a cutting-edge smart home automation system that revolutionizes the way individuals interact with their living spaces. This patent showcases his forward-thinking approach to integrating technology into everyday life.

Career Highlights:

Throughout his illustrious career, Gregory Martin Harrowe has been at the forefront of technological advancements. His work in developing sustainable energy solutions has garnered international recognition, positioning him as a pioneer in the clean energy sector.

Collaborations:

Gregory Martin Harrowe has collaborated with leading research institutions and universities to further his innovative projects. His partnerships have led to the development of cutting-edge technologies that have the potential to shape the future of various industries.

Conclusion:

In conclusion, Gregory Martin Harrowe's passion for innovation and dedication to pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of inventors to think boldly and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…